Form 4 for NUVB Nuvation Bio Inc.
Accepted 2025-06-18 00:00:00 ET · period of report 2025-06-16 · accession 0001415889-25-017658 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-18 | 2025-06-16 | NUVB | Sjogren Colleen | Chief Commercial Off | P - Purchase | $1.81 | +50.0K | 81.0K | +161% | +$90.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-06-16 | P | A | 50,000 | $1.81 | 81,000 | D | — | — | (F1) The price reported is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.795 to $1.82, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price. (F2) Includes 3,000 shares acquired on May 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan. |